Q3 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | VENTYX BIOSCIENCES INC | $23,837,630 | -2.6% | 686,370 | -8.0% | 31.65% | +23.0% |
Q2 2023
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ICOSAVAX INC | $34,856,564 | – | 3,510,228 | – | 36.63% | – | |
New | VENTYX BIOSCIENCES INC | $24,480,936 | – | 746,370 | – | 25.72% | – | |
New | JASPER THERAPEUTICS INC | $11,671,918 | – | 8,519,648 | – | 12.26% | – | |
New | HILLEVAX INC | $9,607,886 | – | 558,923 | – | 10.10% | – | |
TALS | New | TALARIS THERAPEUTICS INC | $8,915,122 | – | 2,932,606 | – | 9.37% | – |
ELEV | New | ELEVATION ONCOLOGY INC | $3,602,616 | – | 2,370,142 | – | 3.79% | – |
KZR | New | KEZAR LIFE SCIENCES INC | $2,030,342 | – | 828,711 | – | 2.13% | – |
Q4 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ELEV | Exit | ELEVATION ONCOLOGY INC | $0 | – | -2,370,142 | – | -3.89% | – |
Exit | JASPER THERAPEUTICS INC | $0 | – | -5,852,982 | – | -6.71% | – | |
KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -828,711 | – | -10.36% | – |
TALS | Exit | TALARIS THERAPEUTICS INC | $0 | – | -2,932,606 | – | -11.20% | – |
Exit | HILLEVAX INC | $0 | – | -558,923 | – | -13.88% | – | |
Exit | ICOSAVAX INC | $0 | – | -3,510,228 | – | -16.11% | – | |
Exit | VENTYX BIOSCIENCES INC | $0 | – | -746,370 | – | -37.85% | – |
Q3 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
Sell | VENTYX BIOSCIENCES INC | $26,056,000 | +134.0% | 746,370 | -18.0% | 37.85% | +144.9% |
Q2 2022
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | ICOSAVAX INC | $20,114,000 | – | 3,510,228 | – | 27.92% | – | |
TALS | New | TALARIS THERAPEUTICS INC | $13,226,000 | – | 2,932,606 | – | 18.36% | – |
New | JASPER THERAPEUTICS INC | $11,296,000 | – | 5,852,982 | – | 15.68% | – | |
New | VENTYX BIOSCIENCES INC | $11,133,000 | – | 910,306 | – | 15.45% | – | |
KZR | New | KEZAR LIFE SCIENCES INC | $6,853,000 | – | 828,711 | – | 9.51% | – |
New | HILLEVAX INC | $6,109,000 | – | 558,923 | – | 8.48% | – | |
ELEV | New | ELEVATION ONCOLOGY INC | $3,318,000 | – | 2,370,142 | – | 4.60% | – |